Xigris

In the US, Xigris (drotrecogin alfa systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Sepsis.

US matches:

• Xigris

UK matches:

• Xigris 20mg powder for solution for infusion, 5mg powder for solution for infusion (SPC)

Ingredient matches for Xigris

Drotrecogin Alfa

Drotrecogin Alfa (activated) is reported as an ingredient of Xigris in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Canada


• Chile


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Hong Kong


• Hungary


• Iceland


• India


• Ireland


• Israel


• Italy


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Poland


• Romania


• Russian Federation


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.